Stocks-COCP-Cocrystal Pharma Inc

COCP Cocrystal Pharma Inc

1.93 -0.06 (-3.02%)
Market OpenDelayed Prices By NASDAQ, in USD
Trade
Trade

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2022: Cocrystal Pharma Inc's revenues decreased by NaN and amounted to 0.00. Net income decreased by 173.79% to -38.84M. Net assets decreased by NaN to 39.57M and EPS decreased from N/A to -4.77.
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
Net Profit Margin
Operating Margin
Return On Investment